InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Continued Listing Status Granted by NASDAQ Hearing Panel
Nov 4, 2022
AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, is able to continue to list its shares on the NASDAQ Capital Market. The company received the notification from Nasdaq Hearings Panel of the Listing Qualifications Department of the Nasdaq Stock Market LLC. The status is subject to ANPC demonstrating compliance with the $1 Bid Price listing rule by Nov. 23, 2022, as well as all other requirements for continued listing. AnPac has been working with the market since being notified earlier this year that the bid price of its listed security had closed at under $1 per share for the previous 30 consecutive business days, meaning the company did not comply with the $1 Bid Rule. The company was given time to comply with the rule; AnPac ultimately requested a hearing before the NASDAQ Hearings Panel to present its financial data and plan, including a share reverse split, to regain compliance with the $1 Bid Rule. The most recent decision was made after that hearing, which was held on Oct. 202, 2022. Based on that decision, AnPac will continue to be listed and its shares will continue to be traded on NASDAQ, pending a final written decision by the exchange’s hearings panel after Nov. 23, 2022.
To view the full press release, visit https://ibn.fm/LhGQa
About AnPac Bio-Medical Science Co. Ltd.
AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a report by Frost & Sullivan, AnPac Bio ranked first globally in multicancer screening and detection-test sample volume, accumulative to January 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com
NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
More News
NTF-Elcac scores groups criticizing BDP projects in Iloilo
MANILA, Philippines – The National Task Force to End Local Communist Armed Conflict (NTF-Elcac) has scored the “hypocrisy” of groups claiming to champion the poor while allegedly discrediting Iloilo’s Barangay Development Program (BDP). This came after Bayan-Panay, in a statement issued on Oct. 15, cited the Commission on Audit’s (COA) 2025 audit report on the
Kehlani live in Manila: Here are the ticket prices
Ticket details for Kehlani's upcoming concert at the SM Mall of Asia Arena on February 15, 2027 have been released.
/file/attachments/orphans/ZahidHamidi1_597968.png)
Court grants stay in M'sian Bar's challenge over Zahid case
Judge gives decision in chamber proceedings, lawyer says.
Rosal slightly accelerates; signal No. 1 still up in 6 areas
MANILA, Philippines — Tropical Cyclone Wind Signal No. 1 (TCWS) remained hoisted over six areas in northern and southern Luzon as Super Typhoon Rosal (international name: Champi) slightly accelerated over east of northern Luzon on Wednesday morning, according to the state weather bureau. In the 5 a.m. weather bulletin of the Philippine Atmospheric, Geophysical, and Astronomical
House panel summons DILG's Remulla, PDEA's Nerez over attempted Laos drugs shipment
The House Committee on Dangerous Drugs has summoned Interior and Local Government Secretary Jonvic Remulla and Philippine Drug Enforcement Agency (PDEA) Director General Undersecretary Isagani Nerez over the attempted shipment of illegal drugs from Laos.
Malaysia bans civil servants from using mapping app Waze, citing links to Israel
Prime Minister Anwar Ibrahim recommends the use of TuJu, a domestic mapping app developed by the Malaysian Highway Authority, as an alternative
Atong Ang out of PH? DOJ chief cannot confirm
Justice Secretary Fredderick Vida on Wednesday said he cannot confirm reports that businessman Atong Ang, the alleged mastermind in the disappearance of several sabungeros, has left the country.
5 ways to heal from a friendship breakup
If you’re navigating the grief and fallout of a difficult friendship breakup, here are a few ways to get by
New reality series helps Filipinos address skin conditions
“Kutis Reveal” follows 12 Filipinos through five months of consultations and treatment—hoping to improve not just their skin but also their confidence and quality of life
De Lima, Diokno, 8 other House lawmakers want China envoy recalled
The lawmakers say the President must 'take decisive action in response to statements and conduct that undermine national sovereignty and threaten the country's security'
Expectation vs. reality: Online seller's Chinese-style shirt ends up on horror character on 'Unang Hirit'
An online seller who posted his Chinese-style shirt on Facebook Marketplace got an unexpected surprise after finding out who actually wore the outfit.
Musk says SpaceX-Tesla merger is ‘a good idea’ as companies form deal committees
'I think it would be a good idea, but it's really up to the special committees of both companies,' Elon Musk says in the first official confirmation that the companies were formally talking
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.